Condition: Endometrial Cancer · Sponsor: University of Aarhus
The goal of this observational case-control study is to investigate the use of DNA-methylation testing in patient-collected urine and vaginal samples to detect endometrial cancer. The study aims to answer the following questions: * Can DNA methylation testing in vaginal and full-void urine samples distinguish endometrial cancer cases from healthy controls? Researchers will compare patient-collected urine and vaginal samples from patients with diagnosed endometrial cancer (cases) to gynaecologically and oncologically healthy controls (controls). Participants will * take a urine and vaginal sample at the hospital. * answer a questionnaire regarding acceptability and preferences of self-sampling methods. * answer a lifestyle questionnaire.
This description comes directly from the study's public registry record.
Karen O. Binderup · +4578420187 · kabind@rm.dk
Mette Tranberg, PhD · +4578420264 · mettrani@rm.dk
Always discuss trial participation with your own doctor first.
| Department of Obstetrics and Gynaecology, Aarhus University Hospital | Aarhus N, Denmark | Recruiting |
| Department of Obstetrics and Gynaecology, Odense University Hospital | Odense, Denmark | Recruiting |
| Department of Orthopaedics, Randers Regional Hospital | Randers, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06846775